Mechanism of Endothelial Dysfunction in Apolipoprotein E-Deficient Mice

Abstract—Endothelium-dependent relaxations mediated by NO are impaired in a mouse model of human atherosclerosis. Our objective was to characterize the mechanisms underlying endothelial dysfunction in aortas of apolipoprotein E (apoE)-deficient mice, treated for 26 to 29 weeks with a lipid-rich Western-type diet. Aortic rings from apoE-deficient mice showed impaired endothelium-dependent relaxations to acetylcholine (10−9 to 10−5 mol/L) and Ca2+ ionophore (10−9 to 10−6 mol/L) and endothelium-independent relaxations to diethylammonium (Z)-1-(N, N-diethylamino)diazen-1-ium-1,2-diolate (DEA-NONOate, 10−10 to 10−5 mol/L) compared with aortic rings from C57BL/6J mice (P <0.05). By use of confocal microscopy of an oxidative fluorescent probe (dihydroethidium), increased superoxide anion (O2−) production was demonstrated throughout the aortic wall but mainly in smooth muscle cells of apoE-deficient mice. CuZn-superoxide dismutase (SOD) and Mn-SOD protein expressions were unaltered in the aorta exposed to hypercholesterolemia. A cell-permeable SOD mimetic, Mn(III) tetra(4-benzoic acid) porphyrin chloride (10−5 mol/L), reduced O2− production and partially normalized relaxations to acetylcholine and DEA-NONOate in apoE-deficient mice (P <0.05). [14C] l-Citrulline assay showed a decrease of Ca2+-dependent NOS activity in aortas from apoE-deficient mice compared with C57BL/6J mice (P <0.05), whereas NO synthase protein expression was unchanged. In addition, cGMP levels were significantly reduced in the aortas of apoE-deficient mice (P <0.05). Our results demonstrate that in apoE-deficient mice on a Western-type fat diet, impairment of endothelial function is caused by increased production of O2− and reduced endothelial NO synthase enzyme activity. Thus, chemical inactivation of NO with O2− and reduced biosynthesis of NO are key mechanisms responsible for endothelial dysfunction in aortas of atherosclerotic apoE-deficient mice.

[1]  S. Tokuno,et al.  Endothelial dysfunction in atherosclerotic mice: improved relaxation by combined supplementation with L‐arginine‐tetrahydrobiopterin and enhanced vasoconstriction by endothelin , 2000, British journal of pharmacology.

[2]  R. Cohen,et al.  Decreased sensitivity to nitric oxide in the aorta of severely hypercholesterolemic apolipoprotein E-deficient mice. , 2000, Journal of cardiovascular pharmacology.

[3]  C. Mallari,et al.  Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. , 2000, American journal of physiology. Heart and circulatory physiology.

[4]  P. Gambert,et al.  Impairment of endothelium-dependent arterial relaxation by high-fat feeding in ApoE-deficient mice: toward normalization by human ApoA-I expression. , 1999, Circulation.

[5]  F. Faraci,et al.  Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  D. Harrison,et al.  Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. , 1999, Biochemical and biophysical research communications.

[7]  T. Lüscher,et al.  Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Tsao,et al.  Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. , 1998, Circulation.

[9]  T. Lüscher,et al.  Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. , 1998, Circulation.

[10]  B. Davidson,et al.  Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. , 1998, Circulation research.

[11]  D. Harrison,et al.  Vascular expression of extracellular superoxide dismutase in atherosclerosis. , 1998, The Journal of clinical investigation.

[12]  J. Zweier,et al.  Validation of Lucigenin (Bis-N-methylacridinium) as a Chemilumigenic Probe for Detecting Superoxide Anion Radical Production by Enzymatic and Cellular Systems* , 1998, The Journal of Biological Chemistry.

[13]  J. Crapo,et al.  Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. , 1997, Archives of biochemistry and biophysics.

[14]  D. Heistad,et al.  Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[15]  R. Weisbrod,et al.  Reduced responsiveness of hypercholesterolemic rabbit aortic smooth muscle cells to nitric oxide. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[16]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[17]  D. Harrison,et al.  Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Milstien,et al.  Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. , 1996, Circulation research.

[19]  K. Hirata,et al.  Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation. , 1996, The American journal of pathology.

[20]  C. Szabó,et al.  Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger , 1996, FEBS letters.

[21]  R. Brandes,et al.  Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. , 1995, Atherosclerosis.

[22]  P. Libby,et al.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.

[23]  A. Quyyumi,et al.  Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. , 1995, The Journal of clinical investigation.

[24]  I. Fridovich,et al.  Stable Mn(III) porphyrins mimic superoxide dismutase in vitro and substitute for it in vivo. , 1994, The Journal of biological chemistry.

[25]  R. Johns,et al.  Inhibition of nitric oxide synthase by a superoxide generating system. , 1993, The Journal of pharmacology and experimental therapeutics.

[26]  K. Tornheim,et al.  Superoxide anion production by rabbit thoracic aorta: effect of endothelium-derived nitric oxide. , 1993, The American journal of physiology.

[27]  D. Harrison,et al.  Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.

[28]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[29]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[30]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[31]  D. Harrison,et al.  Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. , 1991, Circulation research.

[32]  D. Harrison,et al.  Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. , 1990, The Journal of clinical investigation.

[33]  Paul M. Vanhoutte,et al.  The Endothelium: Modulator of Cardiovascular Function , 1990 .

[34]  S. Snyder,et al.  Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[36]  L. Ignarro,et al.  Endothelium‐Derived Relaxing Factor From Pulmonary Artery and Vein Possesses Pharmacologic and Chemical Properties Identical to Those of Nitric Oxide Radical , 1987, Circulation research.

[37]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[38]  Richard J. Jones Heart Disease: A Textbook of Cardiovascular Medicine , 1980 .

[39]  S. Schwartz,et al.  Maintenance of integrity in aortic endothelium. , 1980, Federation proceedings.

[40]  J. D. Smith,et al.  Mouse models of atherosclerosis. , 1998, Laboratory animal science.

[41]  J. Kastelein,et al.  Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. , 1997, The Journal of clinical investigation.

[42]  T. Lüscher,et al.  The Endothelium as a Regulator of Vascular Tone and Growth , 1995 .

[43]  D. Harrison Endothelial dysfunction in atherosclerosis. , 1994, Basic research in cardiology.

[44]  L. Ignarro Biosynthesis and metabolism of endothelium-derived nitric oxide. , 1990, Annual review of pharmacology and toxicology.